USA: Two more blood pressure drugs recalled for potential cancer risk

Share this

Teva Pharmaceuticals has launched a voluntary recall into two drugs used to treat high blood pressure as yet more medications face concerns over a possible cancer risk.

In a statement from Teva posted by the Food and Drug Administration, the recall affects all lots of combination tablets featuring the drugs amlodipine and valsartan and another combo drug featuring amlodipine, valsartan, and hydrochlorothiazide.

The drugs could contain an impurity called N-nitroso-diethylamine (NDEA), which has been classified as a possible human carcinogen, the FDA said.

Patients taking either drugs should contact their doctor or pharmacist for advice or alternative treatments. Stopping the drugs immediately with no comparable alternative could pose a greater risk to patients’ health, said Teva.

In August, the FDA announced an expanded recall of valsartan because products may contain the impurity. Last month, two more recalls were announced: one for the drug irbesartan and a second recall for losartan potassium hydrochlorothiazide tablets.

During an interview in November with USA TODAY, FDA commissioner Scott Gottlieb said the blood pressure drug recalls reflect an increased focus on drug quality to ensure no impurities are present.

Source: BestNewsGH.com


Share this

Kennedy Mornah is an Award Winning Ghanaian Journalist with over two decades of experience in the Ghanaian Media landscape spanning the electronic, print and digital media. He is a Media Consultant, a Corporate MC, Radio and TV Host, Founder and Publisher of the Maritime and Transport Digest Newspaper, Businessman, a Go getter and an optimist. He has worked for renowned media organizations including Diamond Fm in Tamale, Luv Fm in Kumasi, Oman Fm in Accra and Starr Fm in Accra In 2017 he received the Reporter of the Year Award at the Ghana Shippers Awards in Accra, Ghana.

Leave a Reply

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.